Hypoxia-inducible factor-1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma

Oncol Lett. 2022 Jun 28;24(2):284. doi: 10.3892/ol.2022.13404. eCollection 2022 Aug.

Abstract

Metastasis is one of the major reasons for patient mortality in hepatocellular carcinoma (HCC), and the progression of HCC to a metastatic state depends on the local microenvironment. Hypoxia is a key condition affecting the microenvironment of HCC. Currently, various studies have shown that the expression of hypoxia-ainducible factor-1α (HIF-1α) is associated with the invasion and metastasis of HCC. High expression of HIF-1α often leads to poor prognosis in patients with HCC. In this review, the molecular structure of HIF-1α is described, and the expression pattern of HIF-1α in HCC under hypoxia, which is associated with metastasis and poor prognosis in HCC, is explained. The molecular mechanisms of HIF-1α function and the metastasis of HCC are further discussed. The modulation of HIF-1α can reduce sorafenib resistance and improve the prognosis of patients after TACE. Therefore, HIF-1α may be a critical target for inhibiting HCC metastasis in the future.

Keywords: HIF-1α; hepatocellular carcinoma; hypoxia; hypoxia-inducible factor-1α; tumor metastasis.

Publication types

  • Review

Grants and funding

This study was supported by the Natural Science Foundation of Beijing, China (grant nos. 7212171 and 7212172) and the Pilot Project of Public Welfare Development and Reform of Beijing Municipal Medical Research Institutes (2019–6).